Urologic Design 完成 120 万美元 pre-seed 融资，推进尿失禁医疗器械首次人体研究

Angel Investor Forum leads round as Urologic Design prepares for first-in-human study

, /PRNewswire/ -- Urologic Design, a start-up commercializing innovations in urology care, today announced the closing of a $1.2M pre-seed fundraise. The equity funding will help the company develop its first product, a patented medical device for managing urinary incontinence. The investment will also support continued R&D activities, regulatory work, and preparation for the company's first-in-human clinical study.

The oversubscribed round was led by Angel Investor Forum, Connecticut's primary angel group, and joined by HBS Alumni Angels of Boston, Haven Founders Fund, Connecticut Innovations, and Yale Angels, in addition to several individual investors.

"AIF invests in companies addressing meaningful unmet needs with differentiated solutions," said Matthew Stannard, Life Sciences Lead at Angel Investor Forum. "Urologic Design impressed us with its approach to bridging the gap between absorbent products and surgery for managing urinary incontinence. We are excited to support the company as it advances toward first-in-human testing, an important step on the path to commercialization."

The funds will enable Urologic Design to further refine and test its first product—a urethral occlusion device for men. The company has already developed a working prototype, secured IP protection, and conducted extensive bench testing. Preparations are beginning for an initial clinical study involving a small cohort of men with stress urinary incontinence.

"For the 25 million people living with urinary incontinence in the United States, the available options are uncomfortable, cumbersome, and difficult to incorporate into everyday life," says Dr. David Hesse, Co-Founder and Chief Scientific Officer of Urologic Design. "We founded Urologic Design to develop a simple, temporary solution that gives people greater dignity, control, and confidence in managing leakage—all while fitting naturally into their daily lives."

About Urologic Design
Urologic Design is a start-up that commercializes innovations in urology care. The company was founded in 2022 by Dr. David Hesse, who is the Chief Scientific Officer and an Associate Professor of Urology at the Yale School of Medicine. Urologic Design is headquartered in Branford, CT. For more information, visit www.urologicdesign.com.

Urologic Design Media Contact
[email protected]

SOURCE Urologic Design